https://www.selleckchem.com/products/wh-4-023.html
Supplementation with antithrombin (AT) concentrates is now common in the treatment of congenital and acquired AT deficiency. However, there is no established consensus on the target and timing of supplementation. We aimed to elucidate the effects of AT deficiency on the balance between coagulation activation and inhibition using a thrombin generation assay as in vitro global assay. Samples were prepared by admixing commercially acquired AT-deficient plasma with 1% AT activity with pooled normal plasma. The AT activity in each samp
Aimer
Commentaire
Partagez
